News

PharmaForm will develop the drug products to deliver Pear Tree’s confidential drug substances to the vaginal cavity. Stephen Rocamboli, president of Pear Tree Pharmaceuticals, said: “We are pleased

The main goal of this trial is to evaluate the pharmacokinetic, the pharmacodynamic and the safety of Graspa, ERYtech Pharma’s new medicinal product. Approximately 24 patients comprised of

The ‘ZRx Prescriber’ is a Web application that runs on a pocket computer or a personal computer. The tool is used by physicians to fill out prescriptions and

In this six-week, double-blind, parallel group study, patients will be randomized to one of four arms, receiving a low dose or high dose of BL-1020; risperidone, an approved

John Zehner, president and founder of NukeMed and Dose Shield has been named as president and director of Positron Pharmaceuticals. Positron and Positron Pharmaceuticals acquired Dose Shield for

Under the terms of the agreement, Pfizer will pay Pennsylvania School of Medicine $15 million over a three-year period, during which time scientists from Pfizer and Pennsylvania’s School

Final approval of this product is expected upon expiry of patent protection for the brand product in September 2012, as well as any periods of marketing exclusivity that

In this dose-escalating Phase I trial using a modified 3+3 design, MGCD265 is administered orally to patients at an initial starting dose of 24mg/m2 daily on a continuous

Under the terms of the agreement, China Sky One Medical’s wholly-owned subsidiary, Harbin Tian Di Ren Medical Science and Technology Company, will acquire 100% of Jin Chuang’s assets